Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
DexCom Stock Price (Quote) NASDAQ:DXCM
$323.92 ( 0.84% ) Monday, 23rd May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $302.61 | $450.12 | Monday, 23rd May 2022 DXCM stock ended at $323.92. This is 0.84% more than the trading day before Friday, 20th May 2022. During the day the stock fluctuated 4.49% from a day low at $311.64 to a day high of $325.62. |
| 90 days | $302.61 | $539.06 | |
| 52 weeks | $302.61 | $659.45 |
Historical DexCom prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-23 | $322.77 | $325.62 | $311.64 | $323.92 | 597 961 |
| 2022-05-20 | $324.70 | $325.86 | $309.23 | $321.23 | 824 294 |
| 2022-05-19 | $311.00 | $321.46 | $305.01 | $316.12 | 917 203 |
| 2022-05-18 | $327.06 | $329.10 | $306.89 | $308.49 | 1 034 869 |
| 2022-05-17 | $333.69 | $338.15 | $321.39 | $332.16 | 557 069 |
| 2022-05-16 | $334.78 | $339.19 | $323.09 | $324.60 | 685 660 |
| 2022-05-13 | $316.50 | $337.68 | $316.48 | $334.74 | 1 189 216 |
| 2022-05-12 | $309.60 | $320.79 | $302.61 | $311.52 | 1 128 026 |
| 2022-05-11 | $327.20 | $337.95 | $313.38 | $314.94 | 986 932 |
| 2022-05-10 | $340.62 | $345.75 | $318.73 | $327.43 | 818 795 |
| 2022-05-09 | $342.77 | $348.55 | $322.00 | $330.02 | 1 514 199 |
| 2022-05-06 | $372.21 | $373.80 | $347.68 | $351.89 | 1 336 071 |
| 2022-05-05 | $400.99 | $408.84 | $372.30 | $379.29 | 741 249 |
| 2022-05-04 | $397.35 | $409.73 | $377.96 | $406.03 | 895 761 |
| 2022-05-03 | $405.42 | $407.53 | $393.03 | $395.40 | 704 847 |
| 2022-05-02 | $408.96 | $413.79 | $397.52 | $407.14 | 694 818 |
| 2022-04-29 | $412.38 | $431.48 | $405.22 | $408.58 | 1 378 455 |
| 2022-04-28 | $415.00 | $417.67 | $398.27 | $413.23 | 1 169 801 |
| 2022-04-27 | $425.44 | $430.62 | $411.02 | $413.02 | 718 738 |
| 2022-04-26 | $436.28 | $437.80 | $419.75 | $423.50 | 660 239 |
| 2022-04-25 | $439.94 | $450.12 | $435.35 | $442.49 | 618 320 |
| 2022-04-22 | $466.90 | $467.83 | $439.45 | $440.65 | 338 609 |
| 2022-04-21 | $499.12 | $503.78 | $470.21 | $472.41 | 475 200 |
| 2022-04-20 | $491.74 | $502.53 | $482.99 | $496.39 | 541 600 |
| 2022-04-19 | $477.89 | $495.99 | $477.89 | $491.79 | 498 000 |
| 2022-04-18 | $489.88 | $491.99 | $476.11 | $480.63 | 336 000 |
| 2022-04-14 | $499.39 | $500.00 | $487.52 | $492.11 | 333 314 |
| 2022-04-13 | $493.59 | $502.91 | $493.48 | $498.80 | 390 650 |
| 2022-04-12 | $501.17 | $508.78 | $488.51 | $490.28 | 508 329 |
| 2022-04-11 | $498.75 | $501.82 | $490.01 | $492.49 | 417 456 |
| 2022-04-08 | $510.01 | $514.81 | $501.89 | $506.51 | 374 048 |
| 2022-04-07 | $504.28 | $520.71 | $502.37 | $512.52 | 529 400 |
| 2022-04-06 | $508.62 | $511.89 | $500.82 | $509.54 | 619 900 |
| 2022-04-05 | $521.82 | $523.44 | $506.26 | $516.42 | 1 044 200 |
| 2022-04-04 | $530.49 | $539.06 | $520.89 | $522.20 | 821 500 |
| 2022-04-01 | $522.50 | $536.54 | $517.34 | $530.97 | 758 734 |
| 2022-03-31 | $519.97 | $520.76 | $508.32 | $511.60 | 914 368 |
| 2022-03-30 | $513.55 | $522.43 | $506.80 | $519.02 | 617 598 |
| 2022-03-29 | $500.00 | $516.00 | $498.28 | $515.29 | 828 900 |
| 2022-03-28 | $478.78 | $495.35 | $478.78 | $495.08 | 642 700 |
| 2022-03-25 | $481.52 | $486.66 | $475.73 | $480.97 | 965 600 |
| 2022-03-24 | $453.13 | $469.96 | $442.09 | $468.39 | 679 700 |
| 2022-03-23 | $459.98 | $459.98 | $444.84 | $449.31 | 748 100 |
| 2022-03-22 | $455.21 | $468.48 | $454.68 | $464.71 | 432 447 |
| 2022-03-21 | $465.02 | $467.08 | $447.94 | $460.34 | 598 824 |
| 2022-03-18 | $455.29 | $469.43 | $450.00 | $468.05 | 999 312 |
| 2022-03-17 | $435.42 | $456.67 | $434.58 | $454.73 | 811 900 |
| 2022-03-16 | $422.01 | $439.08 | $420.36 | $437.32 | 880 900 |
| 2022-03-15 | $412.41 | $418.20 | $403.29 | $416.08 | 857 200 |
| 2022-03-14 | $388.40 | $417.00 | $388.37 | $407.29 | 1 065 700 |
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes DexCom G4 PLATINUM system for continuous use by ... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
